Matteo Ferrari

Dr. Matteo Carlo Ferrari is Head of the Operational Department of Internal Medicine and Hospital Service of the IRCCS Ospedale Galeazzi - Sant'Ambrogio.

In 1996 he graduated from the Faculty of Medicine and Surgery at the University of Milan, where he specialized in endocrinology and substitution therapy in 2002. In 2010 in Lausanne and in 2014 in Berlin, he received two Master's degrees in the diagnosis and treatment of post-prosthetic infections.

Among his professional experience:

• 1998-1999 – Medical Officer of the Italian Air Force.
• 2003-2010 Heads the Istituto Clinico Humanitas Emergency Department in Rozzano (MI)
• 2011-2012 he is Professor of Biochemistry and General Pathology at the University of Ostrava, Uniludes Campus, in Lugano (Schweiz).

• In 2020, he was part of the Covid-19 Humanitas task force.

In 2002, he created the Internal Perioperative Medicine Service (Hospitalist), designed for patients undergoing orthopedic prosthetic surgery at the l'Istituto Clinico Humanitas, about 30,000 patients were observed.

In outpatient clinical practice, he specializes in endocrinology, paying special attention to thyroid diseases and diabetology.

In terms of research, from 1996 to 2001 he did basic and clinical research in endocrinology at Ospedale Maggiore, Istituto Mario Negri and Istituto Auxologico of Milan. In 1999, he took part in an internship in the Department of Endocrinology at Brown University in Providence (USA) with 6 full publications.

From 2014 to 2021 – Associate Clinical and Educational Professor and Member of the Open Faculty of the Humanitas Medical University.

Special attention to the treatment of osteoarticular infections: since 2011 he is a member of ESCMID (European Society of Clinical Microbiology and Infectious Disease), in particular a member of the Orthopedic Related European Infection Control Group and EBJIS (European Bone and Joint Infection Society); in 2018 an invited member of the International Consensus Meeting on Prosthetic Joint Infections in Philadelphia, USA and since 2019 has been a country delegate of the European Bone and Joint Infection Society (EBJIS) with an active participation in congresses and numerous international multicenter publications.